Levothyroxine
Levothyroxine · LEVOTHYROXINE SODIUM .025 mg/1 · Tablet · Oral · Northwestern Memorial HealthCare
NDC 87448-1502-03 · 1 TABLET in 1 POUCH · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Where it's made
- repack
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Regulatory
- Application
- ANDA209713
- TE code
- AB1,AB2,AB3
- Approval date
- Jan 18, 2019
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Levothyroxine (Tablet)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Northwestern Memorial HealthCare | LEVOTHYROXINE SODIUM .025 mg/1 | Jul 15, 2026 | Jul 29, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Levothyroxine — NDC 87448-1502-03," retrieved September 3, 2026, https://drugdashboards.com/drug/87448150203.
Free to cite with attribution — see how the data is put together.